<p><img src="https://imageproxy.pbkrs.com/https://ik.imagekit.io/invezz/uploads/2023/05/nasdaq-statistics-scaled.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ik.imagekit.io/invezz/uploads/2023/05/nasdaq-statistics-scaled.jpg"/></p>
<p>纳斯达克最近宣布将 Procaps Group 除名，原因是其未能按时完成财务报告标准，这一重大决定突显了企业在遵守监管规定方面面临的困难。</p>
<p>纳斯达克的官方公告确认，该除名将于 2 月 4 日生效。</p>
<p>这一举措标志着这家制药公司面临的重大转折点，现在必须应对场外交易（OTC）专家市场的问题。</p>
<h2>Procaps 除名的影响</h2>
<p>根据纳斯达克的说法，Procaps Group 未能按时提交重要财务报告，导致该公司退出市场。</p>
<p>根据当地媒体《共和国报》的报道，除名是由于 Procaps 未能满足财务报告提交的截止日期。</p>
<p>在过渡到 OTC 专家市场期间，Procaps 承诺保持其运营的完整性，并遵守向证券交易委员会（SEC）的频繁通知，同时预计其当前商业活动不会发生变化。</p>
<p>除名可能对该组织产生重大影响，特别是在投资者关系和现金流方面。</p>
<p>自成为上市公司以来，Procaps 的股价已下降约 89%，与其初始定价相比大幅下滑。</p>
<p>根据彭博社的分析，最近一次交易中股价跌至 1.12 美元，而去年为 4.41 美元。</p>
<h2>董事会和管理层变动</h2>
<p>为应对这些挑战，Procaps 决定立即对董事会进行调整，以恢复公司的市场地位。梅丽莎·安杰利尼女士和卡米洛·卡马乔先生被任命为新任临时联合首席执行官，这是董事会在除名后战略性决定的一部分。</p>
<p>前首席执行官何塞·安东尼奥·维埃拉在过渡阶段辞职。</p>
<p>领导层变动的公告是对 Procaps 公司治理和运营效率进行更大范围、急需审查的一部分。</p>
<p>根据纳斯达克的说法，除名可能加剧投资者对该公司公司治理和运营缺陷的担忧，这些问题必须迅速解决，以便公司重新获得投资者信心。</p>
<h2>在萎缩市场中的前景</h2>
<p>尽管 Procaps 努力向投资者保证日常运营将照常进行，但过渡到 OTC 专家市场可能导致投资者的怀疑，从而导致股市流动性下降。</p>
<p>这一举措可能会加剧 Procaps 在获取资金和与重要市场参与者建立联系方面已经面临的困难。</p>
<p>事情很快会恢复正常，因为该公司的下一步预计将专注于恢复运营、重建投资者信心，并通过遵守市场规定来减少错误财务报告的数量。</p>
<p>最终，持续发展的长期道路和与股东的开放沟通将使 Procaps 更有效地应对这些困难时期。</p>
<p>总之，Procaps Group 从纳斯达克除名为其他处于类似情况的公司敲响了警钟。</p>
<p>随着公司进入 OTC 专家市场的新阶段，强有力的领导和适当的治理将对其恢复和重建投资者信任至关重要。</p>
<p>困难是巨大的，但通过正确的方法和透明度的承诺，Procaps 可能能够重新进入制药行业。</p>
<p>这篇文章的标题是《纳斯达克因财务短缺将哥伦比亚的 Procaps Group 除名》，首次出现在 Invezz 上。</p>

PRCWF

PROCW

PROC

PROCF

<p>纳斯达克已宣布由于未能满足财务报告标准，将于 2 月 4 日将哥伦比亚的 Procaps Group 退市。此决定突显了企业在合规方面面临的挑战。自上市以来，Procaps 的股价已暴跌 89%，将转向 OTC 专家市场，同时保持运营的完整性。该公司已任命新的临时联合首席执行官，并正在进行治理审查。退市引发了对投资者信心的担忧，并可能影响融资和市场关系</p>

<p><img src="https://imageproxy.pbkrs.com/https://ik.imagekit.io/invezz/uploads/2023/05/nasdaq-statistics-scaled.jpg" alt="" original-src="https://ik.imagekit.io/invezz/uploads/2023/05/nasdaq-statistics-scaled.jpg"/></p>
<p>Nasdaq recently announced the removal of the Procaps Group due to its failure to complete financial reporting standards on time, a significant decision that illustrates the difficulty that businesses confront in maintaining compliance with regulatory specifications.</p>
<div class="lb-trans"><p>纳斯达克最近宣布将 Procaps Group 除名，原因是其未能按时完成财务报告标准，这一重大决定突显了企业在遵守监管规定方面面临的困难。</p>
</div><p>Nasdaq’s official announcement confirms that the expulsion will take effect on February 4.</p>
<div class="lb-trans"><p>纳斯达克的官方公告确认，该除名将于 2 月 4 日生效。</p>
</div><p>This move marks a watershed moment for the pharmaceutical company, which now must deal with the problems of the Over-The-Counter (OTC) Expert Market.</p>
<div class="lb-trans"><p>这一举措标志着这家制药公司面临的重大转折点，现在必须应对场外交易（OTC）专家市场的问题。</p>
</div><h2>Effects of Procaps delisting</h2>
<div class="lb-trans"><h2>Procaps 除名的影响</h2>
</div><p>According to Nasdaq, the Procaps Group failed to meet the deadlines for significant financial reports, prompting the company’s withdrawal from the market.</p>
<div class="lb-trans"><p>根据纳斯达克的说法，Procaps Group 未能按时提交重要财务报告，导致该公司退出市场。</p>
</div><p>According to local media La Republica, the delisting occurred due to Procaps’ inability to meet financial report filing deadlines.</p>
<div class="lb-trans"><p>根据当地媒体《共和国报》的报道，除名是由于 Procaps 未能满足财务报告提交的截止日期。</p>
</div><p>During the transition to the OTC Expert Market, Procaps is committed to maintaining its operational integrity and complying with frequent notifications to the Securities and Exchange Commission (SEC), while no changes are expected in its current commercial activities.</p>
<div class="lb-trans"><p>在过渡到 OTC 专家市场期间，Procaps 承诺保持其运营的完整性，并遵守向证券交易委员会（SEC）的频繁通知，同时预计其当前商业活动不会发生变化。</p>
</div><p>Delisting could have a significant impact on the organization, particularly in terms of investor relationships and cash flow.</p>
<div class="lb-trans"><p>除名可能对该组织产生重大影响，特别是在投资者关系和现金流方面。</p>
</div><p>Since becoming a public business, Procaps’ stock price has fallen by around 89%, a considerable reduction from its initial pricing.</p>
<div class="lb-trans"><p>自成为上市公司以来，Procaps 的股价已下降约 89%，与其初始定价相比大幅下滑。</p>
</div><p>According to Bloomberg’s analysis, the stock price fell to $1.12 in the most recent trading session, compared to $4.41 the prior year.</p>
<div class="lb-trans"><p>根据彭博社的分析，最近一次交易中股价跌至 1.12 美元，而去年为 4.41 美元。</p>
</div><h2>Board and management shakeup</h2>
<div class="lb-trans"><h2>董事会和管理层变动</h2>
</div><p>To address these challenges, Procaps has chosen to make immediate changes to its board of directors to restore the company’s market status. Ms. Melissa Angelini and Mr.</p>
<div class="lb-trans"><p>为应对这些挑战，Procaps 决定立即对董事会进行调整，以恢复公司的市场地位。梅丽莎·安杰利尼女士和卡米洛·卡马乔先生被任命为新任临时联合首席执行官，这是董事会在除名后战略性决定的一部分。</p>
</div><p>Camilo Camacho has been named as the new interim co-CEO by the board as part of a strategic decision to modify the company’s course following its delisting.</p>
<div class="lb-trans"><p>前首席执行官何塞·安东尼奥·维埃拉在过渡阶段辞职。</p>
</div><p>José Antonio Vieria, the former CEO, resigned during the transition phase.</p>
<div class="lb-trans"><p>领导层变动的公告是对 Procaps 公司治理和运营效率进行更大范围、急需审查的一部分。</p>
</div><p>The announcement of the leadership transition is part of a larger, much-needed review of Procaps’ corporate governance and operational efficiency.</p>
<div class="lb-trans"><p>根据纳斯达克的说法，除名可能加剧投资者对该公司公司治理和运营缺陷的担忧，这些问题必须迅速解决，以便公司重新获得投资者信心。</p>
</div><p>According to Nasdaq, the delisting may exacerbate investors’ concerns about the business’s corporate governance and operational shortcomings, which must be addressed quickly for the company to regain investor confidence.</p>
<div class="lb-trans"><h2>在萎缩市场中的前景</h2>
</div><h2>Prospects in a shrinking market</h2>
<div class="lb-trans"><p>尽管 Procaps 努力向投资者保证日常运营将照常进行，但过渡到 OTC 专家市场可能导致投资者的怀疑，从而导致股市流动性下降。</p>
</div><p>Despite Procaps’ efforts to assure investors that everyday operations will continue as usual, the transition to the OTC Expert Market may lead to investor scepticism and, as a result, a drop in stock market liquidity.</p>
<div class="lb-trans"><p>这一举措可能会加剧 Procaps 在获取资金和与重要市场参与者建立联系方面已经面临的困难。</p>
</div><p>This action could exacerbate Procaps’ already tough situation in acquiring funding and developing ties with important market participants.</p>
<div class="lb-trans"><p>事情很快会恢复正常，因为该公司的下一步预计将专注于恢复运营、重建投资者信心，并通过遵守市场规定来减少错误财务报告的数量。</p>
</div><p>Things will return to normal soon since the company’s next step is expected to focus on resuming operations, restoring investor faith, and reducing the amount of incorrect financial reports by adhering to market regulations.</p>
<div class="lb-trans"><p>最终，持续发展的长期道路和与股东的开放沟通将使 Procaps 更有效地应对这些困难时期。</p>
</div><p>Eventually, the long-term path of sustained development and open communication with shareholders will enable Procaps to navigate these difficult times more effectively.</p>
<div class="lb-trans"><p>总之，Procaps Group 从纳斯达克除名为其他处于类似情况的公司敲响了警钟。</p>
</div><p>In conclusion, Procaps Group’s delisting from Nasdaq serves as a warning to other companies in similar situations.</p>
<div class="lb-trans"><p>随着公司进入 OTC 专家市场的新阶段，强有力的领导和适当的治理将对其恢复和重建投资者信任至关重要。</p>
</div><p>As the company enters this new phase in the OTC Expert Market, strong leadership and adequate governance will be critical in guiding it to recovery and regaining investors’ trust.</p>
<div class="lb-trans"><p>困难是巨大的，但通过正确的方法和透明度的承诺，Procaps 可能能够重新进入制药行业。</p>
</div><p>The difficulties are substantial, but with the right approaches and promises of transparency, Procaps may be able to re-enter the pharmaceutical sector.</p>
<div class="lb-trans"><p>这篇文章的标题是《纳斯达克因财务短缺将哥伦比亚的 Procaps Group 除名》，首次出现在 Invezz 上。</p>
</div><p>The post Nasdaq delists Colombia’s Procaps Group due to financial shortfalls appeared first on Invezz</p>

纳斯达克因财务短缺将哥伦比亚的 Procaps Group 摘牌